News

Eurocine Vaccines discloses half-year report for July – December 2022

Eurocine Vaccines AB (publ) (“Eurocine Vaccines” or the “Company”) hereby discloses the half-year report for July to December 2022. Below is a summary of the…

Eurocine Vaccines publicerar halvårsrapport för juli – december 2022

Eurocine Vaccines AB (publ) (“Eurocine Vaccines” eller “Bolaget”) publicerar härmed halvårsrapport för juli till december 2022. Nedan följer en kort sammanfattning av rapporten. Fullständig rapport…

Eurocine Vaccines’ Director of Preclinical Development invited to lecture at UCL School of Pharmacy

Eurocine Vaccines (“Eurocine” or the “Company”) announces today that the Company’s Director of Preclinical Development, Dr. Karl Ljungberg, has lectured on DNA and RNA vaccines…

Calendar

Biotechgate Digital Partnering May 2023

As a long term returning participant, Eurocine Vaccines will join the Biotechgate Digital Partnering event in May 2023 to meet with innovators, commercial companies andRead…